Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2025-01-07 Capital/Financing Update
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Ipsen - Half year statement - 2024 12 31
Capital/Financing Update Classification · 1% confidence The document is titled "Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF" and provides specific figures regarding shares and cash held in a liquidity account as of December 31, 2024, along with transaction volumes (purchases and sells) executed between July 1st, 2024, and December 31st, 2024. This content relates to the management of the company's own shares or capital structure, specifically concerning a liquidity agreement (often related to share buybacks or stabilization). This aligns most closely with the 'Transaction in Own Shares' (POS) category, which covers share repurchase/issuance activities. It is not a full financial report (IR/10-K), an earnings release (ER), or a general regulatory filing (RNS).
2025-01-07 English
Ipsen - Décembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references French regulatory articles (Code de commerce and AMF General Regulation) and provides a table detailing the total number of shares and the total gross and net voting rights as of a specific date (December 31, 2024). This structure is characteristic of a mandatory periodic disclosure regarding the capital structure and voting power, which aligns best with a general regulatory filing or a specific capital structure update. Since there is no specific code for a 'Monthly Voting Rights Disclosure' and it is a formal regulatory disclosure, it fits best under the general 'Regulatory Filings' (RNS) or potentially 'Share Issue/Capital Change' (SHA). Given the focus is purely on the count of shares and voting rights, and it's a recurring regulatory report, RNS is the most appropriate general regulatory fallback, although SHA is also plausible. However, RNS is used for general regulatory announcements that don't fit other specific categories. Since this is a formal, periodic regulatory disclosure about the capital structure, RNS is chosen as the best fit among the provided options for a non-standard, mandatory regulatory report.
2025-01-07 French
Ipsen - December 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Monthly information relative to the total number of voting rights and shares composing the share capital' and explicitly references compliance with French Commercial Code and AMF regulations. It provides a table detailing the total number of shares and the total number of voting rights as of a specific date (December 31, 2024). This type of periodic disclosure regarding the capital structure and voting rights is most closely aligned with regulatory reporting concerning share capital changes or major shareholdings, but none of the specific codes perfectly match a 'Monthly Voting Rights Disclosure'. Given the options, it relates to the composition of the share capital and voting rights. It is not an AGM, 10-K, ER, or IR. It is not a Director's Dealing (DIRS) or Major Shareholding Notification (MRQ) which focus on ownership changes by individuals/entities crossing thresholds. Since it is a specific, recurring regulatory disclosure about the total share capital and voting rights, and it doesn't fit the other specific categories like DIV, SHA, or DIRS, the closest fit among the provided options that deals with capital structure reporting, although not perfectly, is 'Share Issue/Capital Change' (SHA) or it could be considered a general 'Regulatory Filing' (RNS). However, since it is a specific, recurring report on the total number of shares and voting rights, which is a fundamental component of capital structure reporting, SHA is a plausible fit, though RNS is the safest fallback. Given the detailed nature of the capital structure data provided, SHA (Share Issue/Capital Change) is chosen as the best fit over the generic RNS, as the data directly pertains to the denominator used in many capital change calculations.
2025-01-07 English
Ipsen - Novembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references French regulatory articles (Code de commerce and AMF General Regulation) and provides a table detailing the total number of shares and voting rights as of November 30, 2024. This type of mandatory monthly disclosure regarding the share capital structure and voting rights is a specific regulatory filing, often related to capital changes or major shareholdings, but the core content is a direct report on the capital structure itself. Given the options, this is a specific regulatory disclosure about the capital structure. While it relates to share capital, it is not a general 'Share Issue/Capital Change' (SHA) announcement, but rather a mandatory periodic report on the current state of voting rights. It fits best under the general 'Regulatory Filings' (RNS) as a specific, recurring regulatory disclosure that doesn't map perfectly to the other specialized codes like DIV, CAP, or SHA, which usually announce an *event*. However, since it is a direct report on the capital structure and voting rights, it is a form of capital/share information disclosure. Given the French context and the nature of the disclosure (total shares/votes), it is a specific regulatory filing. Since there isn't a perfect code for 'Monthly Voting Rights Disclosure', RNS (Regulatory Filings) is the most appropriate fallback for a mandatory, non-event-driven regulatory report. If 'SHA' (Share Issue/Capital Change) is interpreted broadly to include periodic reporting on capital structure, it could fit, but RNS is safer for mandatory periodic regulatory updates that aren't earnings or proxy statements.
2024-12-09 French
Ipsen - November 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Monthly information relative to the total number of voting rights and shares composing the share capital' and provides a table detailing the total number of shares and voting rights as of November 30, 2024. This type of periodic disclosure regarding the share capital structure and voting rights is a specific regulatory requirement in France (AMF regulation). While it relates to share capital, it is not a general financing announcement (CAP) or a transaction in own shares (POS). It is a routine disclosure about the composition of voting rights, which fits best under the general 'Regulatory Filings' (RNS) category as it is a specific, recurring regulatory disclosure that doesn't match the other specialized codes like DIRS, MRQ, or DIV. Given the specific nature of reporting voting rights monthly, it is a regulatory filing.
2024-12-09 English
Ipsen - October 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Monthly information relative to the total number of voting rights and shares composing the share capital" and provides a table detailing the total number of shares and voting rights as of October 31, 2024. It explicitly references compliance with French Commercial Code and AMF regulations. This type of regular, mandatory disclosure regarding the capital structure and voting rights, especially on a monthly basis, is a specific regulatory filing. It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). While it relates to voting rights, it is a factual disclosure of the current count, not the results of a vote (DVA) or a proxy solicitation (PSI). Given the specific nature of reporting share capital and voting rights counts, it fits best under the general 'Regulatory Filings' category (RNS) as a specific, recurring regulatory disclosure that doesn't match the other specialized codes, although it is highly specific data.
2024-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.